{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:00:27Z","timestamp":1790434827955,"version":"4.1.0"},"reference-count":28,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CBM"],"published-print":{"date-parts":[[2017,8,23]]},"DOI":"10.3233\/cbm-160533","type":"journal-article","created":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T13:41:31Z","timestamp":1504273291000},"page":"143-150","source":"Crossref","is-referenced-by-count":9,"title":["Clinical significance of serum 14-3-3 beta in patients with hepatocellular carcinoma"],"prefix":"10.1177","volume":"20","author":[{"given":"Hai","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, The Central Hospital of Linyi, Yishui, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelong","family":"Jiao","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benxia","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangdong","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Central Hospital of Linyi, Yishui, Shandong, China"},{"name":"Department of Clinical Laboratory, Yantaiyuhuangding Hospital, Yantai, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HaiYan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Hemopurification Center, Yantaiyuhuangding Hospital, Yantai, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, People\u2019s Hospital of Weifang, Weifang, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunsheng","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Yantaiyuhuangding Hospital, Yantai, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"issue":"1","key":"10.3233\/CBM-160533_ref1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"10.3233\/CBM-160533_ref2","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/hep.24545","article-title":"Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3- and 6-month periodicities","volume":"54","author":"Trinchet","year":"2011","journal-title":"Hepatology"},{"issue":"4","key":"10.3233\/CBM-160533_ref3","first-page":"CD002799","article-title":"Alpha-foetoprotein and\/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis B","volume":"9","author":"Aghoram","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.3233\/CBM-160533_ref4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/jhep.2002.32089","article-title":"Prognostic prediction and treatment strategy in hepatocellular carcinoma","volume":"35","author":"Bruix","year":"2002","journal-title":"Hepatology"},{"issue":"16","key":"10.3233\/CBM-160533_ref5","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/jnci\/dji237","article-title":"Reporting recommendations for tumor marker prognostic studies (REMARK)","volume":"97","author":"McShane","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.3233\/CBM-160533_ref6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.semcancer.2006.03.004","article-title":"14-3-3 proteins as potential oncogenes","volume":"16","author":"Tzivion","year":"2006","journal-title":"Semin Cancer Biol"},{"issue":"5","key":"10.3233\/CBM-160533_ref7","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1074\/jbc.R100059200","article-title":"14-3-3 proteins: Active cofactors in cellular regulation by serine\/threonine phosphorylation","volume":"277","author":"Tzivion","year":"2002","journal-title":"J Biol Chem"},{"key":"10.3233\/CBM-160533_ref8","doi-asserted-by":"crossref","unstructured":"Z. Li, J. Zhao, Y. Du, H.R. Park, S.Y. Sun, L. Bernal-Mizrachi, A. Aitken, F.R. Khuri and H. Fu, Down-regulation of 14-3-3 zeta suppresses anchorage-independent growth of lung cancer cells through anoikis activation, Proc Natl Acad Sci U S A 105(1) (2008), 162\u2013167.","DOI":"10.1073\/pnas.0710905105"},{"issue":"8","key":"10.3233\/CBM-160533_ref9","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1158\/0008-5472.CAN-08-2765","article-title":"14-3-3 zeta overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival","volume":"69","author":"Neal","year":"2009","journal-title":"Cancer Res"},{"issue":"5","key":"10.3233\/CBM-160533_ref10","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1365-2559.2011.03789.x","article-title":"Overexpression of 14-3-3 \u03b5 predicts tumour metastasis and poor survival in hepatocellular carcinoma","volume":"58","author":"Ko","year":"2011","journal-title":"Histopathology"},{"issue":"1","key":"10.3233\/CBM-160533_ref11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.humpath.2010.01.028","article-title":"Involvement of 14-3-3 \u03b3 overexpression in extrahepatic metastasis of hepatocellular carcinoma","volume":"42","author":"Ko","year":"2011","journal-title":"Hum Pathol"},{"issue":"6","key":"10.3233\/CBM-160533_ref12","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1016\/j.ajpath.2011.08.010","article-title":"Increased expression of 14-3-3\u03b2 promotes tumor progression and predicts extrahepatic metastasis and worse survival in hepatocellular carcinoma","volume":"179","author":"Liu","year":"2011","journal-title":"Am J Pathol"},{"issue":"5","key":"10.3233\/CBM-160533_ref13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.canlet.2011.01.015","article-title":"Silencing of 14-3-3 \u03b6 over-expression in hepatocellular carcinoma inhibits tumor growth and enhances chemosensitivity to cis-diammined dichloridoplatium","volume":"303","author":"Choi","year":"2011","journal-title":"Cancer Lett"},{"issue":"10","key":"10.3233\/CBM-160533_ref14","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/ijc.25907","article-title":"High expression of stratifin is a universal abnormality during the course of malignant progression of early-stage lung adenocarcinoma","volume":"129","author":"Shiba-Ishii","year":"2011","journal-title":"Int J Cancer"},{"issue":"7","key":"10.3233\/CBM-160533_ref15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13075-016-0935-z","article-title":"Serum levels of 14-3-3 \u03b7 protein supplement C-reactive protein and rheumatoid arthritis-associated antibodies to predict clinical and radiographic outcomes in a prospective cohort of patients with recent-onset inflammatory polyarthritis","volume":"18","author":"Carrier","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"10.3233\/CBM-160533_ref16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1756-0500-7-97","article-title":"14-3-3 \u03b2 protein expression in eosinophilic meningitis caused by Angiostrongylus cantonensis infection","author":"Tsai","year":"2014","journal-title":"BMC Res"},{"issue":"8","key":"10.3233\/CBM-160533_ref17","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1002\/pmic.201000449","article-title":"Identification of 14-3-3 \u03b2 in human gastric cancer cells and its potency as a diagnostic and prognostic biomarker","volume":"11","author":"Tseng","year":"2011","journal-title":"Proteomics"},{"issue":"9","key":"10.3233\/CBM-160533_ref18","doi-asserted-by":"crossref","first-page":"e24843","DOI":"10.1371\/journal.pone.0024843","article-title":"The prognostic value of 14-3-3 isoforms in vulvar squamous cell carcinoma cases: 14-3-3 \u03b2 and \u03b5 are independent prognostic factors for these tumors","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"10.3233\/CBM-160533_ref19","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1158\/0008-5472.CAN-08-2765","article-title":"14-3-3 \u03b6 overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival","volume":"69","author":"Christopher","year":"2009","journal-title":"Cancer Res"},{"key":"10.3233\/CBM-160533_ref20","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"Practice guidelines committee, american association for the study of liver diseases, management of hepatocellular carcinoma","volume":"42","author":"Bruix","year":"2005","journal-title":"Hepatology"},{"issue":"17","key":"10.3233\/CBM-160533_ref21","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1016\/j.ejca.2011.07.002","article-title":"Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma","volume":"47","author":"Chun","year":"2011","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.3233\/CBM-160533_ref22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-0030-1247133","article-title":"Current strategy for staging and treatment: the BCLC update and future prospects","volume":"30","author":"Forner","year":"2010","journal-title":"Semin Liver Dis"},{"issue":"8","key":"10.3233\/CBM-160533_ref23","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1007\/s10620-008-0541-2","article-title":"Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B","volume":"54","author":"Kim","year":"2009","journal-title":"Dig Dis Sci"},{"issue":"5 Suppl 1","key":"10.3233\/CBM-160533_ref24","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1053\/j.gastro.2004.09.011","article-title":"Primary liver cancer: Worldwide incidence and trends","volume":"127","author":"Bosch","year":"2004","journal-title":"Gastroenterology"},{"issue":"1","key":"10.3233\/CBM-160533_ref25","first-page":"16","article-title":"Updates in the management of hepatocellular carcinoma","volume":"7","author":"Wong","year":"2011","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.3233\/CBM-160533_ref26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1186\/1471-2407-11-397","article-title":"Aberrant upregulation of 14-3-3 expression serves as an inferior prognostic biomarker for gastric cancer","volume":"11","author":"Zhou","year":"2011","journal-title":"BMC Cancer"},{"issue":"Pt2","key":"10.3233\/CBM-160533_ref27","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1042\/bj3490547","article-title":"Regulation of BAD by cAMP-dependent protein kinase is mediated via phosphorylation of a novel site, Ser155","volume":"349","author":"Lizcano","year":"2000","journal-title":"Biochem J"},{"issue":"10","key":"10.3233\/CBM-160533_ref28","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/ijc.25907","article-title":"High expression of stratifin is a universal abnormality during the course of malignant progression of early-stage lung adenocarcinoma","volume":"129","author":"Shiba-Ishii","year":"2011","journal-title":"Int J Cancer"}],"container-title":["Cancer Biomarkers"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/CBM-160533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:05:24Z","timestamp":1777385124000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/CBM-160533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,23]]},"references-count":28,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/cbm-160533","relation":{},"ISSN":["1875-8592","1574-0153"],"issn-type":[{"value":"1875-8592","type":"electronic"},{"value":"1574-0153","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8,23]]}}}